Cytoreductive surgery for intestinal cancer patients metastatic to the adnexal presenting as primary ovarian cancer.

被引：0
|
作者：
Arik, Zafer
Dizdar, Omer
Yildirim, Mahmut Emre
Ozgu, Emre
Oz, Murat
Terzioglu, Serdar Gokay
Gungor, Tayfun
机构：
[1] Zekai Tahir Burak Women Hlth Educ & Training Hosp, Med Oncol Unit, Ankara, Turkey
[2] Hacettepe Univ, Inst Canc, Dept Med Oncol, Ankara, Turkey
[3] Zekai Tahir Burak Women Hlth Training & Educ Hosp, Gynecol Oncol Unit, Ankara, Turkey
[4] Zekai Tahir Burak Women Hlth Training & Educ Hosp, Gen Surg Unit, Ankara, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e14651
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14651
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Morbidity of rectosigmoid resection in cytoreductive surgery for ovarian cancer. Risk factor analysis
    Fournier, M.
    Huchon, C.
    Ngo, C.
    Bensaid, C.
    Bats, A. S.
    Combe, P.
    le FrereBelda, M. A.
    Fournier, L.
    Berger, A.
    Lecuru, F.
    EJSO, 2018, 44 (06): : 750 - 753
  • [32] Metastatic gallbladder cancer to the ovary presenting as primary ovarian cancer: a case report
    Kim, Chorong
    Hu, Yoon Hyeon
    Lee, Kyoungyul
    Lee, Hyang Ah
    Lee, Dong Hun
    Ouh, Yung-Taek
    JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [33] Metastatic gallbladder cancer to the ovary presenting as primary ovarian cancer: a case report
    Chorong Kim
    Yoon Hyeon Hu
    Kyoungyul Lee
    Hyang Ah Lee
    Dong Hun Lee
    Yung-Taek Ouh
    Journal of Medical Case Reports, 15
  • [34] MORBIDITY OF RECTOSIGMOID RESECTION IN CYTOREDUCTIVE SURGERY FOR OVARIAN CANCER. RISK FACTOR ANALYSIS
    Huchon, C.
    Bats, A. S.
    Berger, A.
    Lecuru, F.
    Fournier, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 315 - 315
  • [35] SPLENECTOMY AS PRIMARY CYTOREDUCTIVE SURGERY IN ADVANCED STAGE EPITHELIAL OVARIAN CANCER
    Akilli, H.
    Karakas, L. Aksoy
    Nihan, H.
    Ayhan, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A429 - A430
  • [36] Utilization of Primary Cytoreductive Surgery for Advanced-Stage Ovarian Cancer
    Bercow, Alexandra
    Stewart, Taylor
    Bregar, Amy J.
    Gockley, Allison
    Mazina, Varvara
    Rauh-Hain, J. Alejandro
    Melamed, Alexander
    JAMA NETWORK OPEN, 2024, 7 (10)
  • [37] Impact of postoperative morbidity on oncologic outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery
    Hirani, Rahim
    Praiss, Aaron
    Choi, Kyung
    Zhou, Qin
    Iasonos, Alexia
    Gardner, Ginger
    Roche, Kara Long
    Sonoda, Yukio
    Chi, Dennis
    Zivanovic, Oliver
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S137 - S137
  • [38] Hypoalbuminemia alone is not a contraindication to primary cytoreductive surgery in advanced ovarian cancer
    Finch, Lindsey
    Dagher, Christian
    Finlan, Michael
    Kahn, Ryan
    Yeoshoua, Effi
    Broach, Vance
    Roche, Kara Long
    Gardner, Ginger
    Sonoda, Yukio
    Abu-Rustum, Nadeem
    Chi, Dennis
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S258 - S259
  • [39] Primary Versus Interval Cytoreductive Surgery in Treatment of Advanced Ovarian Cancer
    Lone, Abdul Rashid
    Ahmad, Mushtaq
    Kour, Sandeep
    Aziz, Sheikh Aejaz
    Banday, Manzoor A.
    Jeelani, Samoon
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 14 - 19
  • [40] EXTENSIVE PRIMARY CYTOREDUCTIVE SURGERY FOR ADVANCED EPITHELIAL OVARIAN-CANCER
    GUIDOZZI, F
    BALL, JHS
    GYNECOLOGIC ONCOLOGY, 1994, 53 (03) : 326 - 330
12345